Literature DB >> 21144441

Seasonal influenza vaccination and the risk of infection with pandemic influenza: a possible illustration of non-specific temporary immunity following infection.

H Kelly1, S Barry, K Laurie, G Mercer.   

Abstract

Four Canadian studies have suggested that receipt of seasonal influenza vaccine increased the risk of laboratory-confirmed infection with 2009 pandemic influenza A(H1N1). During the influenza season of 2009 in Victoria, Australia, this virus comprised 97% of all circulating influenza viruses for which sub-typing was available. We found no evidence that seasonal influenza vaccine increased the risk of, or provided protection against, infection with the pandemic virus. Ferret experiments have suggested protection against pandemic influenza A(H1N1) 2009 from multiple prior seasonal influenza infections but not from prior seasonal vaccination. Modelling studies suggest that influenza infection leads to heterosubtypic temporary immunity which is initially almost complete. We suggest these observations together can explain the apparent discrepant findings in Canada and Victoria. In Victoria there was no recent prior circulation of seasonal influenza and thus no temporary immunity to pandemic influenza. There was no association of seasonal influenza vaccine with pandemic influenza infection. In Canada seasonal influenza preceded circulation of the pandemic virus. An unvaccinated proportion of the population developed temporary immunity to pandemic influenza from seasonal infection but a proportion of vaccinated members of the population did not get seasonal infection and hence did not develop temporary immunity to pandemic influenza. It may therefore have appeared as if seasonal vaccination increased the risk of infection with pandemic influenza A(H1N1) virus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21144441     DOI: 10.2807/ese.15.47.19722-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  24 in total

1.  Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.

Authors:  Rosalind M Eggo; James G Scott; Alison P Galvani; Lauren Ancel Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

2.  Atopic conditions other than asthma and risk of the 2009 novel H1N1 infection in children: a case-control study.

Authors:  Carlos F Santillan Salas; Sonia Mehra; Maria R Pardo Crespo; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2013 Sep-Oct       Impact factor: 2.587

3.  Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness.

Authors:  Shuo Feng; Ashley L Fowlkes; Andrea Steffens; Lyn Finelli; Benjamin J Cowling
Journal:  Epidemiology       Date:  2017-07       Impact factor: 4.822

4.  Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages.

Authors:  Karen L Laurie; William Horman; Louise A Carolan; Kok Fei Chan; Daniel Layton; Andrew Bean; Dhanasekaran Vijaykrishna; Patrick C Reading; James M McCaw; Ian G Barr
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

Review 5.  Partial protection against 2009 pandemic influenza A (H1N1) of seasonal influenza vaccination and related regional factors: Updated systematic review and meta-analyses.

Authors:  Zhi-yuan Li; Jin-yan Chen; Yan-ling Zhang; Wei-ming Fu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.

Authors:  Jennifer R Hamilton; David Sachs; Jean K Lim; Ryan A Langlois; Peter Palese; Nicholas S Heaton
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

7.  Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.

Authors:  Benjamin J Cowling; Vicky J Fang; Hiroshi Nishiura; Kwok-Hung Chan; Sophia Ng; Dennis K M Ip; Susan S Chiu; Gabriel M Leung; J S Malik Peiris
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

8.  The potential effect of temporary immunity as a result of bias associated with healthy users and social determinants on observations of influenza vaccine effectiveness; could unmeasured confounding explain observed links between seasonal influenza vaccine and pandemic H1N1 infection?

Authors:  Natasha S Crowcroft; Laura C Rosella
Journal:  BMC Public Health       Date:  2012-06-20       Impact factor: 3.295

9.  Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Authors:  Wiebke Hellenbrand; Pernille Jorgensen; Brunhilde Schweiger; Gerhard Falkenhorst; Matthias Nachtnebel; Benedikt Greutélaers; Christian Traeder; Ole Wichmann
Journal:  BMC Infect Dis       Date:  2012-05-31       Impact factor: 3.090

10.  Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season.

Authors:  Yi-Chun Lo; Jen-Hsiang Chuang; Hung-Wei Kuo; Wan-Ting Huang; Yu-Fen Hsu; Ming-Tsan Liu; Chang-Hsun Chen; Hui-Hsun Huang; Chi-Hsi Chang; Jih-Haw Chou; Feng-Yee Chang; Tzou-Yien Lin; Wen-Ta Chiu
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.